Histological Findings in a Failed Corneal Riboflavin–UVA Collagen Cross-linking Performed for Progressive Keratoconus

Purpose: To report the histological and immunohistochemical findings in a cornea removed from a patient who had undergone collagen cross-linking (CXL) with riboflavin and ultraviolet-A for progressive keratoconus. CXL was performed following the Siena protocol. Two years post-CXL, a visual acuity impairment in the treated eye secondary to corneal stromal opacity had occurred, together with corneal thinning and flattening. Methods: The excised cornea was formalin-fixed, paraffin-embedded, and examined microscopically. Deparaffinized 4-&mgr;m sections were stained with hematoxylin–eosin and Masson trichrome. Further tissue sections were subjected to immunohistochemical evaluation of CD34 and Ki-67 antigens. Results: Histologically, there was no scar tissue in the failed cornea. The biomicroscopic stromal opacity corresponded microscopically to an acellular area, devoid of keratocytes, and to compaction of the lamellar collagen. Amorphous, weakly eosinophilic interlamellar deposits, extending from the anterior to the posterior two thirds of the stroma, were noted. Conclusions: CXL is a promising procedure for the treatment of progressive keratoconus with minimal reported side effects. In the present case, we speculate that the short corneal soaking time (15 minutes according to the Siena protocol) may have resulted in inefficient ultraviolet-A blocking, thermal injury, and deeper keratocyte death. Inadequate keratocyte stem cells reservoir could also play a role in individual cases.

[1]  Jatin N Ashar,et al.  Long-term results of riboflavin ultraviolet A corneal collagen cross-linking for Keratoconus in Italy: the Siena eye cross study. , 2010, American journal of ophthalmology.

[2]  G. Snibson,et al.  Collagen cross‐linking: a new treatment paradigm in corneal disease – a review , 2010, Clinical & experimental ophthalmology.

[3]  G. Wollensak Histological changes in human cornea after cross‐linking with riboflavin and ultraviolet A , 2010, Acta ophthalmologica.

[4]  N. Gokhale,et al.  Diclofenac-induced Acute Corneal Melt After Collagen Crosslinking for Keratoconus , 2010, Cornea.

[5]  E. Sarchielli,et al.  Effects of riboflavin/UVA corneal cross‐linking on keratocytes and collagen fibres in human cornea , 2010, Clinical & experimental ophthalmology.

[6]  E. Spörl,et al.  [Corneal scar development after cross-linking in keratoconus]. , 2010, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[7]  R. Kleinert,et al.  [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome]. , 2010, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[8]  E. Spörl,et al.  Narbenbildung nach Hornhautvernetzung beim Keratokonus , 2010, Der Ophthalmologe.

[9]  C. Faschinger,et al.  Beidseitiges Einschmelzen der Hornhaut nach beidseitigem simultanen Kollagen-Crosslinking bei Keratokonus und Down-Syndrom , 2010, Der Ophthalmologe.

[10]  Theo Seiler,et al.  Complication and failure rates after corneal crosslinking , 2009, Journal of cataract and refractive surgery.

[11]  C. Mazzotta,et al.  Corneal crosslinking: Riboflavin concentration in corneal stroma exposed with and without epithelium , 2009, Journal of cataract and refractive surgery.

[12]  Cristina Tommasi,et al.  Treatment of Progressive Keratoconus by Riboflavin-UVA-Induced Cross-Linking of Corneal Collagen: Ultrastructural Analysis by Heidelberg Retinal Tomograph II In Vivo Confocal Microscopy in Humans , 2007, Cornea.

[13]  Theo Seiler,et al.  Keratocyte Apoptosis After Corneal Collagen Cross-linking Using Riboflavin/UVA Treatment , 2004, Cornea.

[14]  B. Stuck,et al.  Laser induced thermal injury of rabbit cornea and treatment with anti-inflammatory agents , 1985, Documenta Ophthalmologica.

[15]  T. Seiler,et al.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. , 2003, American journal of ophthalmology.